SEAN DRIGGERS: Open Payments
NPI 1295150951 · WAXAHACHIE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 36 payments from 10 companies in 2025. Trend: 2023 $495 · 2024 $769 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $202 |
| PFIZER INC. | 9 | $175 |
| Medtronic, Inc. | 2 | $162 |
| Boston Scientific Corporation | 3 | $79 |
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Amgen Inc. | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: LEQVIO, SYMPLICITY G3, ELIQUIS, WATCHMAN FLX, VYNDAQEL, BodyGuardian, WAINUA, VERQUVO.
Industry payments across TX — which companies pay providers there.
